Y. Nancy Wong

Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors

Patrick Y. S. Lam, Prabhakar K. Jadhav, Charles J. Eyermann et al. · Science · 1994 · 836 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America

Scott Grimm, Heidi J. Einolf, Steven D. Hall et al. · Drug Metabolism and Disposition · 2009 · 306 citations

Medicine, Pharmacokinetics, Pharmacology +17

A Double‐Blind, Placebo‐Controlled, Ascending‐Dose Evaluation of the Pharmacokinetics and Tolerability of Modafinil Tablets in Healthy Male Volunteers

Y. Nancy Wong, Donna Simcoe, Linda N. Hartman et al. · The Journal of Clinical Pharmacology · 1999 · 159 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors

Antoinette R. Tan, Eric H. Rubin, Diana C. Walton et al. · Clinical Cancer Research · 2009 · 137 citations

Medicine, Oncology, Pharmacology +14

Characterization of Recombinant Human Carboxylesterases: Fluorescein Diacetate as a Probe Substrate for Human Carboxylesterase 2

Jie Wang, Eric T. Williams, Joanne Bourgea et al. · Drug Metabolism and Disposition · 2011 · 132 citations

Life Sciences, Biochemistry, Molecular Biology +11